Literature DB >> 23065859

Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.

J Kaijser1, T Bourne, L Valentin, A Sayasneh, C Van Holsbeke, I Vergote, A C Testa, D Franchi, B Van Calster, D Timmerman.   

Abstract

In order to ensure that ovarian cancer patients access appropriate treatment to improve the outcome of this disease, accurate characterization before any surgery on ovarian pathology is essential. The International Ovarian Tumor Analysis (IOTA) collaboration has standardized the approach to the ultrasound description of adnexal pathology. A prospectively collected large database enabled previously developed prediction models like the risk of malignancy index (RMI) to be tested and novel prediction models to be developed and externally validated in order to determine the optimal approach to characterize adnexal pathology preoperatively. The main IOTA prediction models (logistic regression model 1 (LR1) and logistic regression model 2 (LR2)) have both shown excellent diagnostic performance (area under the curve (AUC) values of 0.96 and 0.95, respectively) and outperform previous diagnostic algorithms. Their test performance almost matches subjective assessment by experienced examiners, which is accepted to be the best way to classify adnexal masses before surgery. A two-step strategy using the IOTA simple rules supplemented with subjective assessment of ultrasound findings when the rules do not apply, also reached excellent diagnostic performance (sensitivity 90%, specificity 93%) and misclassified fewer malignancies than did the RMI. An evidence-based approach to the preoperative characterization of ovarian and other adnexal masses should include the use of LR1, LR2 or IOTA simple rules and subjective assessment by an experienced examiner.
Copyright © 2013 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23065859     DOI: 10.1002/uog.12323

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  29 in total

Review 1.  Ultrasound in gynecological cancer: is it time for re-evaluation of its uses?

Authors:  Daniela Fischerova; David Cibula
Journal:  Curr Oncol Rep       Date:  2015-06       Impact factor: 5.075

2.  Combined Systemic and Hysteroscopic Intra-Amniotic Injection of Methotrexate Associated with Hysteroscopic Resection for Cervical Pregnancy: A Cutting-Edge Approach for an Uncommon Condition.

Authors:  Attilio Di Spiezio Sardo; Mariana da Cunha Vieira; Antonio Simone Laganà; Benito Chiofalo; Salvatore Giovanni Vitale; Mariamaddalena Scala; Marianna De Falco; Carmine Nappi; Ursula Catena; Giuseppe Bifulco
Journal:  Eurasian J Med       Date:  2017-02

Review 3.  Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.

Authors:  Juliane M Liberto; Sheng-Yin Chen; Ie-Ming Shih; Tza-Huei Wang; Tian-Li Wang; Thomas R Pisanic
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

4.  Evaluation of IOTA Simple Ultrasound Rules to Distinguish Benign and Malignant Ovarian Tumours.

Authors:  Sugandha Garg; Amarjit Kaur; Jaswinder Kaur Mohi; Preet Kanwal Sibia; Navkiran Kaur
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 5.  In 2014, can we do better than CA125 in the early detection of ovarian cancer?

Authors:  Joshua G Cohen; Matthew White; Ana Cruz; Robin Farias-Eisner
Journal:  World J Biol Chem       Date:  2014-08-26

Review 6.  Ultrasound evaluation of ovarian masses and assessment of the extension of ovarian malignancy.

Authors:  Francesca Moro; Rosanna Esposito; Chiara Landolfo; Wouter Froyman; Dirk Timmerman; Tom Bourne; Giovanni Scambia; Lil Valentin; Antonia Carla Testa
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.629

7.  The chronological change in transvaginal ultrasound images of a hemorrhagic ovarian cyst observed during infertility treatment: A case report and literature review.

Authors:  Yu Fujii; Yu Wakimoto; Maya Omote; Yukiko Sugiyama; Yuji Ukita; Toru Kato; Atushi Fukui; Hiroaki Shibahara
Journal:  Clin Case Rep       Date:  2021-07-09

8.  Multicentre external validation of IOTA prediction models and RMI by operators with varied training.

Authors:  A Sayasneh; L Wynants; J Preisler; J Kaijser; S Johnson; C Stalder; R Husicka; Y Abdallah; F Raslan; A Drought; A A Smith; S Ghaem-Maghami; E Epstein; B Van Calster; D Timmerman; T Bourne
Journal:  Br J Cancer       Date:  2013-05-14       Impact factor: 7.640

9.  Pelvic mass, ascites, hydrothorax: a malignant or benign condition? Meigs syndrome with high levels of CA 125.

Authors:  Guglielmo Stabile; Giulia Zinicola; Federico Romano; Antonio Simone Laganà; Chiara Dal Pozzolo; Giuseppe Ricci
Journal:  Prz Menopauzalny       Date:  2021-05-25

10.  Comparison of the Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients With Adnexal Masses.

Authors:  Le Qian; Qinwen Du; Meijiao Jiang; Fei Yuan; Hui Chen; Weiwei Feng
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.